Archive for the ‘Pulmonary function’ Category - Part 5

Nasal Positive Pressure Ventilation in Patients with Acute Respiratory Failure (5)

The ICU team judged that criteria for an immediate intubation were present, but that the risk of a bronchopulmonary infection due to a possibly prolonged intubation period was high in this setting of deep immunosuppression. In additiqp, an index of heart graft rejection according to the Texas scale was severe enough (No. 6-7) on a […]

Nasal Positive Pressure Ventilation in Patients with Acute Respiratory Failure (4)

Case Reports Case 1 This 49-year-old male patient had suffered from severe coronary artery disease for 15 years (two myocardial infarctions, followed by two coronary artery bypass grafts) when he received a heart transplant in 1987 because of left ventricular failure and persistent angina. Two years later, in the context of a cytomegalovirus infection probably […]

Nasal Positive Pressure Ventilation in Patients with Acute Respiratory Failure (3)

We therefore decided to assess closely the added time consumption for our health-care team in managing a group of patients primarily submitted to NPPV in whom, for different reasons, intubation and mechanical ventilation were clearly indicated, but not immediately possible. The precise measurement of the amount of time spent with these patients, which appeared to […]

Nasal Positive Pressure Ventilation in Patients with Acute Respiratory Failure (2)

Since 1987, several studies were designed in order to evaluate whether NPPV could also be used in patients with acute respiratory failure; however, if the long-term use of NPPV seems to be characterized by minimal side effects (nasal abrasion;* mask leaks; abdominal distension), NPPV in acute situations is not simple to use. Some patients ventilated […]

Nasal Positive Pressure Ventilation in Patients with Acute Respiratory Failure (1)

Tracheal intubation and mechanical ventilation can successfully provide respiratory support and allow the survival of many patients suffering from acute or acute-on-chronic respiratory failure; however, nasotracheal or orotracheal intubation or tracheostomy may by themselves be a source of added morbidity, and severe complications have been described with these techniques. Furthermore, the endotracheal tube itself may […]

Prognostic Value off Bronchoalveolar Lavage Lymphocyte Count in Recently Diagnosed Pulmonary Sarcoidosis (11)

Recently, Ward et al showed that a high BAL lymphocyte count was found in subjects with acute-onset sarcoidosis, such as that in erythema nodosum and uveitis, entities which have a good prognosis. Therefore, their data, like ours, suggest that a high BAL lymphocyte percentage is not related to lung function impairment. buy birth control online […]

Prognostic Value off Bronchoalveolar Lavage Lymphocyte Count in Recently Diagnosed Pulmonary Sarcoidosis (10)

Therefore, the study population was more homogeneous than in previous reports. Although histologic confirmation was obtained in only 48 of 98 patients, in the others, the diagnosis of sarcoidosis was strongly supported by the typical clinical presentation and elimination of other diseases by the long follow-up (mean, 25.6 months). We believe it is, therefore, quite […]

Prognostic Value off Bronchoalveolar Lavage Lymphocyte Count in Recently Diagnosed Pulmonary Sarcoidosis (9)

We also evaluated whether the responsiveness to steroid treatment could be predicted by the percentage of BAL lymphocytes. The difference in the pulmonary functions before and during steroid treatment (mean duration of treatment, 3.5 months) were correlated to BAL lymphocyte counts. Weak but significant correlations were found between the lymphocyte count and AFEVj (r=0.41, p=0.031) […]

Prognostic Value off Bronchoalveolar Lavage Lymphocyte Count in Recently Diagnosed Pulmonary Sarcoidosis (8)

On the other hand, 36 subjects out of the 80 not requiring treatment at the first visit (45 percent) had a lymphocyte count ^30 percent; the difference in the mean proportion of high-intensity alveolitis between these two groups was not significant (p=0.087). antibiotics levaquin

Prognostic Value off Bronchoalveolar Lavage Lymphocyte Count in Recently Diagnosed Pulmonary Sarcoidosis (7)

These two patients were, however, included in the treated group. The treated patients were older (mean, 41.1 years) than the nontreated patients (mean: 36.1 yr), but this difference was not statistically significant (p = 0.12). The two groups had similar lavage volume recovery (nontreated, 56.2 percent; treated, 60.5 percent [p = 0.15]; lavage total number […]

Pages: Prev 1 2 3 4 5 6 7 8 9 10 ... 12 13 14 Next
anosiahuman.com